CNCR
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR
Delisted
CNCR was delisted on the 27th of May, 2025.
1 hedge funds and large institutions have $1.85K invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2025 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Holders
1
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 | -$348K | |
| 2 | -$346K | |
| 3 | -$271K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$29.7K |
| 5 |
Morgan Stanley
New York
|
-$13.7K |
